Published in J Prev Med Hyg on June 10, 2015
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet (2013) 7.86
Colorectal cancer. Lancet (2013) 5.40
Adherence with colorectal cancer screening guidelines: a review. Prev Med (2004) 2.87
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA (2014) 2.42
A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res (2013) 2.33
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med (2012) 2.13
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
Improving cancer screening adherence: using the "teachable moment" as a delivery setting for educational interventions. Am J Manag Care (2004) 1.84
A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol (2014) 1.79
Global cancer patterns: causes and prevention. Lancet (2013) 1.67
Breast cancer statistics and markers. J Cancer Res Ther (2014) 1.23
P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med (2013) 1.22
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. Health Technol Assess (2014) 1.14
How can polygenic inheritance be used in population screening for common diseases? Genet Med (2013) 1.10
Review of the association between meat consumption and risk of colorectal cancer. Nutr Res (2013) 1.08
Update on prevention and screening of cervical cancer. World J Clin Oncol (2014) 1.07
Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol (2014) 1.07
Recent advances in cancer vaccines: an overview. Jpn J Clin Oncol (2008) 1.06
An overview on the implementation of HPV vaccination in Europe. Hum Vaccin (2011) 1.04
Cigarette smoking and breast cancer risk: a long latency period? Int J Cancer (2002) 1.03
The effect of two types of sms-texts on the uptake of screening mammogram: a randomized controlled trial. Prev Med (2011) 1.01
Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99
Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev (2014) 0.98
Predictors of cervical cancer screening adherence in the United States: a systematic review. J Adv Pract Oncol (2014) 0.97
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors. J Immunother Cancer (2013) 0.96
Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin (2013) 0.95
Personalized screening for cancers: should we consider polygenic profiling? Per Med (2013) 0.94
[Methods to increase participation in cancer screening programmes]. Epidemiol Prev (2012) 0.94
The road ahead for cervical cancer prevention and control. Curr Oncol (2014) 0.94
Cruciferous vegetables and risk of colorectal neoplasms: a systematic review and meta-analysis. Nutr Cancer (2013) 0.93
A framework provided an outline toward the proper evaluation of potential screening strategies. J Clin Epidemiol (2013) 0.93
Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl) (2014) 0.92
HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol Oncol (2010) 0.92
Cancer immunotherapy: sipuleucel-T and beyond. Pharmacotherapy (2011) 0.90
Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Ann Oncol (2013) 0.89
Breast size and breast cancer: a systematic review. J Plast Reconstr Aesthet Surg (2014) 0.89
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol (2013) 0.89
Understanding patient options, utilization patterns, and burdens associated with breast cancer screening. J Womens Health (Larchmt) (2014) 0.89
Options for screening for colorectal cancer. Scand J Gastroenterol Suppl (2003) 0.89
Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol (2014) 0.88
Body mass index and risk of breast cancer: a nonlinear dose-response meta-analysis of prospective studies. Sci Rep (2014) 0.88
The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs. Front Oncol (2014) 0.88
HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions. PLoS One (2014) 0.87
From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice. Cancers (Basel) (2014) 0.86
Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances. Ther Adv Vaccines (2014) 0.86
Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer (2013) 0.85
The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens. J Clin Virol (2014) 0.84
Review of economic evidence in the prevention and early detection of colorectal cancer. Health Econ Rev (2013) 0.84
Screening mammography benefit controversies: sorting the evidence. Radiol Clin North Am (2014) 0.84
Cervical cancer: Can it be prevented? World J Clin Oncol (2014) 0.82
A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking. Asian Pac J Cancer Prev (2014) 0.82
Translational cancer research: balancing prevention and treatment to combat cancer globally. J Natl Cancer Inst (2014) 0.82
Vitespen: a preclinical and clinical review. Future Oncol (2009) 0.82
Compliance with breast and cervical cancer screening programs in women: results from a population-based study. Tumori (2013) 0.81
Overweight, obesity, oxidative stress and the risk of breast cancer. Asian Pac J Cancer Prev (2014) 0.81
Economic evaluation of colorectal cancer (CRC) screening. Best Pract Res Clin Gastroenterol (2013) 0.81
The role of genome sequencing in personalized breast cancer prevention. Cancer Epidemiol Biomarkers Prev (2014) 0.80
[Responsible cancer screening]. Ned Tijdschr Geneeskd (2011) 0.80
A person-focused model of care for the twenty-first century: a system-of-systems perspective. Popul Health Manag (2014) 0.79
Cervical cancer screening and psychosocial barriers perceived by patients. A systematic review. Contemp Oncol (Pozn) (2014) 0.79
Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol (2010) 0.79
Breast cancer detection using sonography in women with mammographically dense breasts. BMC Med Imaging (2014) 0.78
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. Ann Oncol (2014) 0.78
Expensive cancer drugs and just health care. Best Pract Res Clin Gastroenterol (2014) 0.78
The cancer screening monitoring system: indicators for organised programmes and possible extension to spontaneous screening. Pathologica (2013) 0.78
Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides. Front Immunol (2014) 0.77
Cervical premalignant lesions and their management. J Turk Ger Gynecol Assoc (2014) 0.77
Plasma methylated septin 9: a colorectal cancer screening marker. Expert Rev Mol Diagn (2014) 0.77
Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening. Eur J Cancer Prev (2015) 0.77
MD-miniRNA could be a more accurate biomarker for prostate cancer screening compared with serum prostate-specific antigen level. Tumour Biol (2015) 0.77
Advances in managing breast cancer: a clinical update. F1000Prime Rep (2014) 0.76
Genomic medicine: a question of value: despite the promise of personalized medicine, genomic testing has yet to prove its cost-effectiveness. Cancer Cytopathol (2014) 0.76
An analysis of mass screening strategies using a mathematical model: comparison of breast cancer screening in Japan and the United States. J Epidemiol (2014) 0.76
Promoting colorectal cancer screening in public health outreach campaigns. Hum Factors (2011) 0.76
The impact of HPV female immunization in Italy: model based predictions. PLoS One (2014) 0.76
[Factors influencing the participation in colorectal screening]. Orv Hetil (2014) 0.76
Engineering healthcare as a service system. Stud Health Technol Inform (2010) 0.76
To screen or nor to screen: the prostate cancer dilemma. Asian J Androl (2015) 0.76
Estimating the cost-effectiveness of modern screening mammography programmes. Evid Based Med (2013) 0.76
Breast cancer mortality trends in Italy by region and screening programme, 1980-2008. J Med Screen (2014) 0.76
HPV and Cervical Dysplasia in Adolescents: A Progressive March Toward Prevention. J Pediatr Adolesc Gynecol (2014) 0.76